Ping An Ventures

Ping An Ventures is the corporate venture capital arm of Ping An Insurance (Group) Company of China, one of China's largest insurance and financial services conglomerates. Founded in 2012 with RMB 1 billion (~$150 million) of seed capital from Ping An Insurance, the firm is headquartered in Pudong, Shanghai and holds the distinction of being the first VC fund launched out of China's financial industry. Ping An Ventures invests across fintech, healthcare, consumer, and technology verticals — spanning domestic and overseas opportunities — with a focus on middle-to-late growth rounds, pre-IPO, and PIPE transactions that align with Ping An's own digital transformation roadmap. The firm has made approximately 160 investments across its history, with check sizes typically ranging from $3 million to $50 million. To extend its global reach, Ping An Ventures launched the Hong Kong-based Global Voyager fund at $1 billion to source healthcare and fintech assets in the United States, Israel, and Singapore, and has targeted up to $1.3 billion across two additional healthcare-focused growth-stage funds. Notable portfolio companies include Didi Chuxing, Meituan-Dianping, Oscar Health, Payoneer, Taulia, Hycor Biomedical, Fabric Genomics, and Tmunity Therapeutics. Recent exits include eToro and Fabric Genomics, acquired by GeneDx for $51 million in April 2025. Ping An Ventures operates with a lean team of eight investment professionals and maintains a disciplined approach to portfolio construction, concentrating on companies where Ping An's insurance, fintech, and healthcare networks create tangible strategic advantage. The firm functions as both a financial investor and a strategic partner, connecting portfolio companies to Ping An's vast distribution ecosystem across China and select global markets.